Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand

  1. Home

  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    (0096–0116) Antiphospholipid Syndrome Poster
    Location: Poster Hall
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0096: Performance Assessment of Lupus Anticoagulant Tests Using Taipan and Ecarin Snake Venom Clotting Times: An International Study from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Core Laboratories
    Location: Poster Hall
    Abstract Poster Presenter: Doruk Erkan, MD, MPH – Hospital for Special Surgery
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0097: Transient Ischemic Attack in Antiphospholipid Antibody-positive Patients: Retrospective and Prospective Results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
    Location: Poster Hall
    Abstract Poster Presenter: Zeynep Belce Erton, MD – SUNY Downstate Medical Center
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0098: Predictors of Mortality in Antiphospholipid Antibody Positive Patients: Prospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository “Registry”
    Location: Poster Hall
    Abstract Poster Presenter: yasaman ahmadzadeh, MD – Roger Williams Medical Center
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0099: Cell-bound Complement Activation Products in Antiphospholipid Antibody-positive Patients Without Other Systemic Autoimmune Diseases
    Location: Poster Hall
    Abstract Poster Presenter: Doruk Erkan, MD, MPH – Hospital for Special Surgery
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0100: The Clinical Relevance of Different Antiphospholipid Antibody Profiles in Pediatric Rheumatology Patients
    Location: Poster Hall
    Abstract Poster Presenter: Jheel Pandya, MD (she/her/hers) – Hospital for Special Surgery
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0101: Non-Criteria Antiphospholipid Antibodies and Calprotectin as Potential Biomarkers in Pediatric Antiphospholipid Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Elizabeth Sloan, MD – UT Southwestern
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0102: The Subtype and Prognosis of Acute Myocardial Infarction in Antiphospholipid Syndrome Patients
    Location: Poster Hall
    Abstract Poster Presenter: Can Huang, MD, PhD (she/her/hers) – Peking Union Medical College Hospital
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0103: Criteria and Non-criteria Antiphospholipid Autoantibodies Screening in Women with Unexplained Fetal Death, Pre-eclampsia And/or Fetal Growth Restriction: A Cross-sectional Study
    Location: Poster Hall
    Abstract Poster Presenter: Arthur Mageau, MD, MSc – Université Paris Cité
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0104: Cluster Analysis of Antiphospholipid Antibodies Associated Adverse Pregnancy Outcome Patients: Based on a 13-year Longitudinal Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Xiaofeng Zeng, MD (he/him/his) – Peking Union Medical College Hospital Department of Rheumatology and Clinical Immunology
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0105: Characterization of B-Cell Subsets in Antiphospholipid Syndrome Patients: Implications for Disease Phenotype and Pathogenesis
    Location: Poster Hall
    Abstract Poster Presenter: Xiaofeng Zeng, MD (he/him/his) – Peking Union Medical College Hospital Department of Rheumatology and Clinical Immunology
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0106: Positive Antiphospholipid Antibodies Are Associated with a Higher Risk of Cerebral Microbleeds
    Location: Poster Hall
    Abstract Poster Presenter: Junna Ye, MD – Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0107: Impact of Antiphospholipid Syndrome on Mortality of Hospitalized Ischemic Stroke Patients: A Retrospective Analysis of the National Inpatient Sample Database 2020
    Location: Poster Hall
    Abstract Poster Presenter: Sami Rabah, MD (he/him/his) – Lincoln medical center
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0108: Decoding Antiphospholipid Syndrome Laboratory Test Outcomes in a Large Multicenter Electronic Health Record Database
    Location: Poster Hall
    Abstract Poster Presenter: Emily Balczewski, BA – University of Michigan
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0109: Persistent Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Bruna Fonseca, PhD – University of Michigan
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0110: Neutrophil Extracellular Traps as Mediators of Antiphospholipid Antibody-Induced Trophoblast Dysfunction and Fetal Loss
    Location: Poster Hall
    Abstract Poster Presenter: Christine Rysenga, BS (she/her/hers) – University of Michigan
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0111: Hippo-YAP1-CCN2 Signaling by Microvascular Endothelial Cells Licenses Vascular Smooth Muscle Cell Proliferation in Antiphospholipid Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Eliza Pei-Suen Tsou, PhD – University of Michigan
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0112: Molecular Stratification of Antiphospholipid Syndrome Patients Through Integrative Analysis of the Whole-blood RNA Transcriptome
    Location: Poster Hall
    Abstract Poster Presenter: Amala Ambati, MD – University of Michigan
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0113: Serum Myeloperoxidase (MPO)-DNA Complexes and Serum Calprotectin Differentiate Isolated Thrombotic Antiphospholipid Syndrome from Isolated Obstetric Antiphospholipid Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Liang Ruyu – Peking University
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0114: Platelets Are Highly Activated and Could Participate in Immune Abnormality of APS
    Location: Poster Hall
    Abstract Poster Presenter: Xiaofeng Zeng, MD (he/him/his) – Peking Union Medical College Hospital Department of Rheumatology and Clinical Immunology
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0115: Risk Factors of First Thrombosis in Obstetric Antiphospholipid Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: liang luo, MD – Department of Chinese Medicine, the People's Hospital of Yubei District of Chongqing City, Chongqing, China; Department of Rheumatology and Immunology, Peking University People's Hospital
    Antiphospholipid Syndrome
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0116: Integrated Metabolomic and Proteomic Analyses Stratified Patients with Antiphospholipid Syndrome According to Their Atherothrombotic Risk
    Location: Poster Hall
    Abstract Poster Presenter: Chary Lopez-Pedrera, PhD – IMIBIC - Reina Sofia Hospital
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    9:00 AM – 10:00 AM PT
    13M118: The Future of Antiphospholipid Syndrome (APS): 2023 ACR/EULAR APS Classification Criteria and Beyond
    Location: Room 31A-C
    Moderator: Nina Kello, MD – Northwell Health
    Moderator: Julie Schwartzman-Morris, MD, MS – Northwell Health Physician Partners
    Antiphospholipid Syndrome
     CME: 1 hours
  • Monday, Nov 13th
    9:00 AM – 9:20 AM PT
    Rethinking APS with the Guidance of New APS Classification Criteria
    Location: Room 31A-C
    Speaker: Doruk Erkan, MD, MPH – Hospital for Special Surgery
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    9:20 AM – 9:30 AM PT
    Q&A
    Location: Room 31A-C
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    9:30 AM – 9:50 AM PT
    Disentangling APS Through Pathogenesis-Informed Sub-Phenotyping
    Location: Room 31A-C
    Speaker: Jason Knight, MD, PhD – University of Michigan
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    9:50 AM – 10:00 AM PT
    Q&A
    Location: Room 31A-C
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    2:00 PM – 3:30 PM PT
    13M141: Abstracts: Antiphospholipid Syndrome (1603–1608)
    Location: Room 25A-C
    Abstract Moderator: Maximilian Konig, MD – The Johns Hopkins University School of Medicine
    Abstract Moderator: Robert Roubey, MD – University of North Carolina
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    2:00 PM – 2:10 PM PT
    1603: Infection-Associated Antiphospholipid Antibodies and Their Potential Role in Sepsis Outcomes
    Location: Room 25A-C
    Presenting Author: Katarina Kmetova, BSc, MSc – Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    2:15 PM – 2:25 PM PT
    1604: First and Recurrent Thrombosis Risk After 4,454 Patient-Years of Follow-Up: Prospective Results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
    Location: Room 25A-C
    Presenting Author: Jonathan Thaler, MD (he/him/his) – Hospital for Special Surgery
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    2:30 PM – 2:40 PM PT
    1605: Complement Activation as a Marker of Thrombosis Risk in Antiphospholipid Antibody Positive Patients: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
    Location: Room 25A-C
    Presenting Author: Cecile Yelnik, PhD – lille university
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    2:45 PM – 2:55 PM PT
    1606: Purinergic Signaling as a Potential Therapeutic Target for APS Thromboinflammation
    Location: Room 25A-C
    Presenting Author: NaveenKumar Somanathapura, PhD – University of Mysore, Karnataka, India
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    3:00 PM – 3:10 PM PT
    1607: Autoantibodies to Transcription Factor a Mitochondria Link Mitochondrial Damage and Thrombosis in Systemic Lupus Erythematosus
    Location: Room 25A-C
    Presenting Author: Eduardo Gomez-Banuelos, MD, PhD (he/him/his) – The Johns Hopkins University
    Antiphospholipid Syndrome
  • Monday, Nov 13th
    3:15 PM – 3:25 PM PT
    1608: Plasma Proteomic Profiling in Antiphospholipid Antibody-positive Patients with Different Clinical Phenotypes: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry
    Location: Room 25A-C
    Presenting Author: Alexander Pine, MD, PhD – VA Connecticut/Yale School of Medicine
    Antiphospholipid Syndrome